Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Fine Chemical Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113582937A details a metal-free isoxazole synthesis using TPGS-750-M in water, offering significant cost reduction and environmental benefits for pharmaceutical manufacturing.
Patent CN104341276B details a novel asymmetric synthesis route for Δ3-2-hydroxybakuchiol, offering high purity and scalable manufacturing solutions for pharmaceutical intermediates.
Advanced preparation method for 4,4'-diaminobenzenesulphonamide via chlorosulfonation. Delivers high-purity dye intermediates with optimized yield and cost efficiency.
Novel Grignard coupling method ensures high-purity surfactant intermediates. Reduces steric hindrance and improves sulfonation efficiency for reliable industrial scale manufacturing and cost reduction.
Novel one-step oxidative coupling method for bisphosphine oxides reduces costs and improves scalability for pharmaceutical intermediate manufacturing.
Patent CN102942451A details a green method for 1,2-diol production using recyclable selenium polymers, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN107602368B reveals a green two-step method for 2-pentylanthraquinone, offering cost reduction and high purity for hydrogen peroxide manufacturing intermediates.
Patent CN114836486B details a novel monooxygenase method for synthesizing chiral beta-amino alcohols, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN108358871B reveals a high-yield synthesis for Photoinitiator 369 intermediates, offering significant cost reduction and safer manufacturing conditions for UV curing materials.
Advanced synthesis of chiral bis[N,O] cyclopalladium complexes via patent CN108658802A. Offers high yield, cost reduction, and scalable manufacturing for fine chemical intermediates.
Novel ruthenium-catalyzed visible light method for gamma-hydroxy ketones offers mild conditions and high atom economy for pharma intermediates.
Novel 4-step synthesis from dimethyl isophthalate offers high yield and purity for electronic component coatings, reducing purification complexity.
Patent CN106866377A reveals advanced AlI3-carbodiimide ether cleavage. Enables cost reduction in pharmaceutical intermediate manufacturing with high yield.
Patent CN115710194B enables continuous MGDA production with 98.5% yield. Eliminate NTA impurities and reduce costs in chelating agent manufacturing.
Patent CN107892698B details a solvent-free ruthenium catalyzed selective borylation method offering cost reduction and high purity for pharmaceutical intermediate manufacturing.
Patent CN105753768B details a green two-step synthesis of nitrogen heterocycles from lactones, offering cost reduction and scalable manufacturing for pharma intermediates.
Patent CN105017188A details a metal-catalyzed radical cyclohalogenation method for high-purity 3-halomethyl-2,3-dihydrobenzofuran compounds, offering cost reduction and scalable manufacturing.
Advanced copper-catalyzed synthesis for unsaturated fatty chain alcohols. High purity, scalable production for flavor and fragrance industries.
Patent CN117720445A reveals ionic liquid catalysis for high-purity thermal paper chemicals. Achieve significant cost reduction and supply chain reliability with green synthesis.
Discover efficient synthesis of benzofuranone 1,4-diketones via patent CN118480018A. Safe Mo(CO)6 source ensures cost reduction and supply reliability for pharma intermediates.